Related Experiment Video
Updated: Aug 16, 2026
Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
Published on: June 6, 2020
Can we better prioritize resources for cost-utility research?
Peter J Neumann1, Allison B Rosen, Dan Greenberg
1Harvard School of Public Health, Boston, MA 02115, USA. pneumann@hsph.harvard.edu.
Insights
Cost-utility analyses (CUAs) often focus on pharmaceuticals and surgery, but underrepresent key health issues like mental health and substance abuse. Research funding should better align with disease burden and public health priorities.
Area of Science:
- Health Economics
- Health Services Research
- Public Health Policy
Background:
- Cost-utility analyses (CUAs) are crucial for evaluating healthcare interventions.
- Understanding the scope of published CUAs is essential for assessing research priorities.
Purpose of the Study:
- To analyze 512 CUAs published between 1976-2001.
- To determine intervention types, disease burden alignment, and coverage of Healthy People 2010 priorities.
Main Methods:
- Comparative analysis of CUA disease coverage against U.S. disease burden rankings.
- Assessment of CUA alignment with Healthy People 2010 health priorities.
Main Results:
- CUAs predominantly studied pharmaceuticals (40%) and surgical procedures (16%).
- Overrepresentation in cerebrovascular disease, diabetes, breast cancer, and HIV/AIDS.
- Underrepresentation in depression, bipolar disorder, injuries, and substance abuse; limited focus on Healthy People 2010 areas like physical activity.
Conclusions:
- Published CUAs partially reflect disease burden but neglect significant health concerns.
- Need for strategic resource allocation in CUA research to maximize societal benefit.
Purpose:
We examined 512 published cost-utility analyses (CUAs) in the U.S. and other developed countries from 1976 through 2001 to determine: 1) the types of interventions studied; 2) whether they cover diseases and conditions with the highest burden; and, 3) to what extent they have covered leading health concerns defined by the Healthy People 2010 report.
Data And Methods:
We compared rankings of the most common diseases covered by the CUAs to rankings of U.S. disease burden. We also examined the extent to which CUAs covered key Healthy People 2010 priorities.
Results:
CUAs have focused mostly on pharmaceuticals (40%) and surgical procedures (16%). When compared to leading causes of DALYs, the data show overrepresentation of CUAs in cerebrovascular disease, diabetes, breast cancer, and HIV/AIDS, and underrepresentation in depression and bipolar disorder, injuries, and substance abuse disorders. Few CUAs have targeted Healthy People 2010 areas, such as physical activity.
Conclusions:
Published CUAs are associated with burden measures, but have not covered certain important health problems. These discrepancies do not alone indicate that society has been targeting resources for research inefficiently, but they do suggest the need to formalize the question of where each CUA research dollar might do the most good.
More Related Videos
Related Concept Videos
01:28Methods of Medium Optimization
00:48Optimal Foraging
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:25Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.